Ginkgo Bioworks Holdings, Inc. DNA
10.76 USD +0.91 (+9.24%)
At closeNov 3, 2026, 4:43 PM EST
10.76 0.00 -0.02%
After hours · Nov 3, 4:43 PM ET
10.03 Day range 10.80
5.37 52-week range 18.22
- YTD
- +29.48%
- 1 year
- -15.87%
Analyst view
Price target (mean) 7.00 -34.9% downside
Now 10.76
- Target (low)
- 5.00
- Target (mean)
- 7.00
- Target (high)
- 9.00
Ratings (0m) 3 0 buy · 1 hold · 2 sell
- Strong buy0
- Buy0
- Hold1
- Sell1
- Strong sell1
Recommendation trend
- This month 3
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.58 | -0.58 – -0.58 | 0.00 | 0.0% | 21.58M | -44.4% | 1 |
| Next quarter | -0.82 | -0.82 – -0.82 | -1.42 | +42.3% | 23.85M | -28.6% | 1 |
| Current year | -3.20 | -3.20 – -3.20 | -3.66 | +12.5% | 85.03M | -50.0% | 1 |
| Next year | -2.90 | -2.90 – -2.90 | -3.20 | +9.4% | 96.40M | +13.4% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 4, 2026 | BTIG | Reiterated | Sell | Sell |
| Aug 7, 2026 | TD Cowen | Downgrade | Buy | Hold |
| Mar 12, 2026 | BTIG | Maintained | Sell | Sell |
| Jan 8, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 25, 2025 | BTIG | Maintained | Sell | Sell |
| Sep 20, 2024 | TD Cowen | Maintained | Buy | Buy |
| Aug 23, 2024 | BTIG | Maintained | Sell | Sell |
| Jul 9, 2024 | Goldman Sachs | Maintained | Sell | Sell |
| Jun 26, 2024 | BTIG | Maintained | Sell | Sell |
| May 15, 2024 | BTIG | Downgrade | Neutral | Sell |
| May 15, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 10, 2024 | William Blair | Downgrade | Market Perform | Underperform |
| Mar 1, 2024 | TD Cowen | Maintained | Outperform | Outperform |
| Jan 23, 2024 | Goldman Sachs | Maintained | Sell | Sell |
| Jan 22, 2024 | Goldman Sachs | Maintained | Sell | Sell |
| Nov 15, 2023 | Raymond James | Downgrade | Outperform | Market Perform |
| Nov 14, 2023 | Raymond James | Downgrade | Outperform | Market Perform |
| Nov 9, 2023 | BTIG | Downgrade | Buy | Neutral |
| Jun 5, 2023 | Goldman Sachs | Maintained | Sell | Sell |
| Jun 2, 2023 | Goldman Sachs | Downgrade | Neutral | Sell |
| May 11, 2023 | William Blair | Downgrade | Outperform | Market Perform |
| Nov 29, 2022 | Berenberg | Initiated | — | Buy |
| Oct 4, 2022 | Morgan Stanley | Initiated | — | Equal-Weight |
| Aug 16, 2022 | BTIG | Maintained | — | Buy |
| Aug 16, 2022 | Raymond James | Maintained | — | Outperform |
| Jun 16, 2022 | Jefferies | Maintained | — | Buy |
| May 18, 2022 | B of A Securities | Downgrade | Neutral | Underperform |
| Mar 2, 2022 | Cowen & Co. | Initiated | — | Outperform |
| Feb 23, 2022 | Goldman Sachs | Initiated | — | Neutral |
| Feb 1, 2022 | B of A Securities | Initiated | — | Neutral |